Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
6 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Beneficial effect of corticosteroids in preventing mortality in patients receiving tocilizumab to treat severe COVID-19 illness.
Int J Infect Dis. 2020 Dec;101:290-297. doi: 10.1016/j.ijid.2020.09.1486. Epub 2020 Oct 6.
Int J Infect Dis. 2020.
PMID: 33035673
Free PMC article.
Methylprednisolone Pulses Plus Tacrolimus in Addition to Standard of Care vs. Standard of Care Alone in Patients With Severe COVID-19. A Randomized Controlled Trial.
Solanich X, Antolí A, Rocamora-Blanch G, Padullés N, Fanlo-Maresma M, Iriarte A, Mitjavila F, Capdevila O, Riera-Mestre A, Bas J, Vicens-Zygmunt V, Niubó J, Calvo N, Bolivar S, Rigo-Bonnin R, Mensa-Vilaró A, Arregui L, Tebe C, Videla S, Hereu P, Corbella X.
Solanich X, et al. Among authors: padulles n.
Front Med (Lausanne). 2021 Jun 14;8:691712. doi: 10.3389/fmed.2021.691712. eCollection 2021.
Front Med (Lausanne). 2021.
PMID: 34195214
Free PMC article.
Item in Clipboard
Pragmatic, open-label, single-center, randomized, phase II clinical trial to evaluate the efficacy and safety of methylprednisolone pulses and tacrolimus in patients with severe pneumonia secondary to COVID-19: The TACROVID trial protocol.
Solanich X, Antolí A, Padullés N, Fanlo-Maresma M, Iriarte A, Mitjavila F, Capdevila O, Molina M, Sabater J, Bas J, Mensa-Vilaró A, Niubó J, Calvo N, Bolivar S, Rigo-Bonnin R, Arregui L, Tebé C, Hereu P, Videla S, Corbella X.
Solanich X, et al. Among authors: padulles n.
Contemp Clin Trials Commun. 2021 Mar;21:100716. doi: 10.1016/j.conctc.2021.100716. Epub 2021 Jan 19.
Contemp Clin Trials Commun. 2021.
PMID: 33495742
Free PMC article.
Review.
Item in Clipboard
Inhibition of SARS-CoV-2 replication using calcineurin inhibitors: are concentrations required clinically achievable?
Solanich X, Padullés N, Niubó J, Videla S, Antolí A, Rocamora-Blanch G, Corbella X.
Solanich X, et al. Among authors: padulles n.
J Intern Med. 2021 Jun;289(6):926-927. doi: 10.1111/joim.13264. Epub 2021 Feb 25.
J Intern Med. 2021.
PMID: 33634528
Free PMC article.
No abstract available.
Item in Clipboard
Predictors of Infliximab Trough Concentrations in Inflammatory Bowel Disease Patients Using a Repeated-Measures Design.
Santacana E, Rodríguez-Alonso L, Padullés A, Guardiola J, Bas J, Rodríguez-Moranta F, Serra K, Morandeira F, Colom H, Padullés N.
Santacana E, et al. Among authors: padulles n.
Ther Drug Monit. 2020 Feb;42(1):102-110. doi: 10.1097/FTD.0000000000000669.
Ther Drug Monit. 2020.
PMID: 31283556
Item in Clipboard
External Evaluation of Population Pharmacokinetic Models of Infliximab in Patients With Inflammatory Bowel Disease.
Santacana E, Rodríguez-Alonso L, Padullés A, Guardiola J, Rodríguez-Moranta F, Serra K, Bas J, Morandeira Biology F, Colom H, Padullés N.
Santacana E, et al. Among authors: padulles n.
Ther Drug Monit. 2018 Feb;40(1):120-129. doi: 10.1097/FTD.0000000000000476.
Ther Drug Monit. 2018.
PMID: 29200097
Item in Clipboard
Cite
Cite